Lucid Engage vs Otofonix Groove

The Lucid Engage is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.2/5 in our lab testing, ranking #14 among 65 OTC devices tested. Priced at $850, this behind-the-ear rechargeable device has received our Expert's Choice Award in both 2023 and 2024. In our testing, the Engage demonstrated strong speech clarity in quiet environments, scoring 4.3/5—a full 1.46 points above the OTC category average. Speech understanding in noisy settings scored 2.4/5, which is above the category average by 0.94 points but remains mixed in absolute terms. Own-voice comfort was solid at 3.6/5, exceeding the category average by over a point, which should help with natural-sounding self-perception during conversations. The device's main weakness is feedback handling, scoring 2.6/5—nearly 2 points below the category average of 4.54/5. Users may experience more whistling or feedback artifacts compared to other OTC options. Music streaming quality was mixed at 2.4/5, slightly above average but not a standout feature. The Lucid Engage is well-suited for consumers prioritizing speech clarity in everyday quiet-to-moderate listening situations who can accept trade-offs in feedback stability. Buyers in this price range may also consider alternatives like the Sony CRE-E10 or Lexie B2 Plus, which scored higher in our testing. The Engage supports both iPhone and Android streaming and offers rechargeable convenience.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.